These medications are licensed in the UK for specific indications and prescribed according to NICE guidance, primarily for managing type 2 diabetes and, in some cases, obesity
50+ brands
Our customers have demonstrated a clear gap in supply and demand, so were making it easy for everyone to share their experience and be a part of advocating for better access to the medications they need, said Andrew Dudum, CEO and co-founder of Hims & Hers
V., Pratley, R
With this approval, and by launching a generic for Saxenda, we will provide patients in the US the first ever generic GLP-1 product specifically indicated for weight loss, said Ernie Richardsen, senior vice president, Head of US Commercial Generics at Teva
Both peptides improve a constellation of metabolic markers, and the differences here may ultimately matter more than the weight loss gap for certain populations